Signalling defects and cellular interactions (2)

Lupus

Volumn 17, Issue 3, 2008, Pages 247-250

  Datta, Syamal K ^a   Mauri, C ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

ANTIGEN RECOGNITION; AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CELL INTERACTION; CONFERENCE PAPER; HUMAN; IMMUNOPATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION;

ANIMALS; AUTOIMMUNITY; B-LYMPHOCYTES; CELL COMMUNICATION; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TOLL-LIKE RECEPTORS;

EID: 42549152019     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307088249     Document Type: Conference Paper

References (23)

1. Jury, EC, Isenberg, DA, Mauri, C, Ehrenstein, MR. Atorvastatin restores Lck expression and lipid raft-associated signaling in T cells from patients with systemic lupus erythematosus. J Immunol 2006; 177: 7416-7422.
2. Ehrenstein, MR, Jury, EC, Mauri, C. Statins for atherosclerosis - as good as it gets? N Engl J Med 2005; 352: 73-75 [comment].
3. Datta, SK. Major peptide autoepitopes for nucleosome-centered T and B cell interaction in human and murine lupus. Ann NY Acad Sci 2003; 987: 79-90.
4. Kang, H-K, Michaels, MA, Berner, BR, Datta, SK. Very low-dose tolerance with nucleosomal peptides controls lupus and induces potent regulatory T cell subsets. J Immunol 2005; 174: 3247-3255.
5. Kang, HK, Liu, M, Data, SK. Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells. J Immunol 2007; 178: 7849-7858.
6. Leadbetter, EA, Rifkin, IR, Hohlbaum, AM, Beaudette, BC, Shlomchik, MJ, Marshak-Rothstein, A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002; 416: 595-598.
7. Barton, GM, Kagan, JC, Medzhitov, R. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol 2006; 7: 49-56 [see comment].
8. Berland, R, Fernandez, L, Kari, E, et al. Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice. Immunity 2006; 25: 429-440.
9. Subramanian, S, Tus, K, Li, QZ, et al. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. In: Proceedings of the National Academy of Sciences of the United States of America, vol.103. 2006. p. 9970-9975.
10. Deane, JA, Bolland, S. Nucleic acid-sensing TLRs as modifiers of autoimmunity. J Immunol 2006; 177: 6573-6578.
11. Wu, X, Peng, SL. Toll-like receptor 9 signaling protects against murine lupus. Arthritis Rheum 2006; 54: 336-342.
12. Christensen, SR, Shupe, J, Nickerson, K, Kashgarian, M, Flavell, RA, Shlomchik, MJ. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 2006; 25: 417-428.
13. Sen, R. Control of B lymphocyte apoptosis by the transcription factor NF-kappaB. Immunity 2006; 25: 871-883.
14. Kim, SJ, Gershov, D, Ma, X, Brot, N, Elkon, KB. I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation. J Exp Med 2002; 196: 655-665.
15. Jiang, N, Reich, CF, Monestier, M, Pisetsky, DS. The expression of plasma nucleosomes in mice undergoing in vivo apoptosis. Clin Immunol 2003; 106: 139-147.
16. Licht, R, van Bruggen, MC, Oppers-Walgreen, B, Rijke, TP, Berden, JH. Plasma levels of nucleosomes and nucleosome-autoantibody complexes in murine lupus: effects of disease progression and lipopolyssacharide administration. Arthritis Rheum 2001; 44: 1320-1330.
17. Vinuesa, CG, Cook, MC, Angelucci, C, et al. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 2005; 435: 452-458.
18. Datta, SK, Kalled, SL. CD40-CD40 ligand interaction in autoimmune disease. Arthritis Rheum 1997; 40: 1735-1745.
19. Iwai, H, Abe, M, Hirose, S, et al. Involvement of inducible costimulator-B7 homologous protein costimulatory pathway in murine lupus nephritis. J Immunol 2003; 171: 2848-2854.
20. Zeller, GC, Hirahashi, J, Schwarting, A, Sharpe, AH, Kelley, VR. Inducible co-stimulator null MRL-Faslpr mice: uncoupling of autoantibodies and T cell responses in lupus. J Am Soc Nephrol 2006; 17: 122-130.
21. Tada, Y, Koarada, S, Tomiyoshi, Y, et al. Role of inducible costimulator in the development of lupus in MRL/lpr mice. Clin Immunol 2006; 120: 179-188.
22. Gotsman, I, Grabie, N, Gupta, R, et al. Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule. Circulation 2006; 114: 2047-2055.
23. Kumar, KR, Li, L, Yan, M, et al. Regulation of B cell tolerance by the lupus susceptibility gene Ly108. Science 2006; 312: 1665-1669 [see comment].